• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us

Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations

Creso Pharma Shares - ASX CPH Share Price

Creso Pharma Shares Jumps 12% after Securing New Purchase Orders (ASX:CPH)

By Kiryll Prakapenka, Tuesday, 05 October 2021

The Creso Pharma [ASX:CPH] shares soared in early morning trade after the company announced its wholly-owned Canadian subsidiary, Mernova, secured over $800,000 in new purchase orders.

ASX MXC Share Price - MGC Pharmaceuticals Shares ASX

MGC Pharmaceuticals Share Price Up on Order Announcement (ASX:MXC)

By Kiryll Prakapenka, Thursday, 30 September 2021

MGC Pharmaceuticals Ltd [ASX:MXC] share price is currently up 6.90%. The MGC Pharmaceuticals Ltd [ASX:MXC] announced that its distribution partner placed an order for 1,000 units of MXC’s CimetrA on an expedited basis.

ASX MXC Share Price - MGC Pharmaceuticals Share Price

MGC Pharmaceuticals Shares Lift on Landmark UK Import Permit (ASX:MXC)

By Kiryll Prakapenka, Tuesday, 14 September 2021

MGC Pharmaceuticals said this marks the first time an epilepsy treatment containing THC and still undergoing clinical trials was approved by UK authorities for import. The news saw MGC Pharmaceuticals [ASX:MXC] shares jump 10% at the time of writing.

ASX HZR - Hazer Shares

Hazer Share Price Sinks on $7 Million Capital Raise Update (ASX:HZR)

By Kiryll Prakapenka, Monday, 13 September 2021

The Hazer Group [ASX:HZR] share price sinks as the hydrogen tech developer completes a $7 million placement. Hazer will also invite eligible shareholders to participate in a share purchase plan to raise up to $7 million.

ASX RNO - Rhinomed Share Price

Rhinomed Share Price Surges 20% on Government Deal (ASX:RNO)

By Kiryll Prakapenka, Friday, 10 September 2021

The Rhinomed [ASX:RNO] share price is soaring this morning after the Victorian Department of Health placed initial orders for one million Rhinoswabs for SARS-CoV-2 testing.

ASX IMU - Imugene Share Price

Imugene Share Price Sink 7% after Flagging Three New Trials (ASX:IMU)

By Kiryll Prakapenka, Wednesday, 01 September 2021

The Imugene [ASX:IMU] share price is floundering today on the back of an announcement regarding its HER-Vaxx immunotherapy in HER-2 positive gastric cancer trial.

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 27
  • Go to Next Page »

Primary Sidebar

Technology Categories

  • Technology
  • Artificial Intelligence
  • Bitcoin
  • Cryptocurrency
  • Energy
  • Financial Technology
  • Bio Technology

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988